7-21725834-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001277115.2(DNAH11):​c.7290C>T​(p.Phe2430Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.494 in 1,609,990 control chromosomes in the GnomAD database, including 201,438 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.42 ( 14627 hom., cov: 32)
Exomes 𝑓: 0.50 ( 186811 hom. )

Consequence

DNAH11
NM_001277115.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 2.22

Publications

18 publications found
Variant links:
Genes affected
DNAH11 (HGNC:2942): (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013]
DNAH11 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant 7-21725834-C-T is Benign according to our data. Variant chr7-21725834-C-T is described in ClinVar as Benign. ClinVar VariationId is 93694.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.22 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.508 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001277115.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAH11
NM_001277115.2
MANE Select
c.7290C>Tp.Phe2430Phe
synonymous
Exon 45 of 82NP_001264044.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAH11
ENST00000409508.8
TSL:5 MANE Select
c.7290C>Tp.Phe2430Phe
synonymous
Exon 45 of 82ENSP00000475939.1

Frequencies

GnomAD3 genomes
AF:
0.425
AC:
64490
AN:
151802
Hom.:
14635
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.278
Gnomad AMI
AF:
0.530
Gnomad AMR
AF:
0.431
Gnomad ASJ
AF:
0.407
Gnomad EAS
AF:
0.214
Gnomad SAS
AF:
0.515
Gnomad FIN
AF:
0.484
Gnomad MID
AF:
0.392
Gnomad NFE
AF:
0.512
Gnomad OTH
AF:
0.429
GnomAD2 exomes
AF:
0.453
AC:
110673
AN:
244124
AF XY:
0.464
show subpopulations
Gnomad AFR exome
AF:
0.268
Gnomad AMR exome
AF:
0.416
Gnomad ASJ exome
AF:
0.404
Gnomad EAS exome
AF:
0.201
Gnomad FIN exome
AF:
0.483
Gnomad NFE exome
AF:
0.510
Gnomad OTH exome
AF:
0.465
GnomAD4 exome
AF:
0.501
AC:
730108
AN:
1458070
Hom.:
186811
Cov.:
39
AF XY:
0.502
AC XY:
364277
AN XY:
724940
show subpopulations
African (AFR)
AF:
0.265
AC:
8872
AN:
33442
American (AMR)
AF:
0.418
AC:
18498
AN:
44298
Ashkenazi Jewish (ASJ)
AF:
0.402
AC:
10481
AN:
26052
East Asian (EAS)
AF:
0.228
AC:
9051
AN:
39660
South Asian (SAS)
AF:
0.533
AC:
45559
AN:
85426
European-Finnish (FIN)
AF:
0.484
AC:
25756
AN:
53264
Middle Eastern (MID)
AF:
0.423
AC:
2439
AN:
5762
European-Non Finnish (NFE)
AF:
0.523
AC:
580905
AN:
1109892
Other (OTH)
AF:
0.474
AC:
28547
AN:
60274
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
16622
33244
49866
66488
83110
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16526
33052
49578
66104
82630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.424
AC:
64482
AN:
151920
Hom.:
14627
Cov.:
32
AF XY:
0.424
AC XY:
31437
AN XY:
74222
show subpopulations
African (AFR)
AF:
0.278
AC:
11505
AN:
41428
American (AMR)
AF:
0.430
AC:
6561
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.407
AC:
1414
AN:
3470
East Asian (EAS)
AF:
0.215
AC:
1112
AN:
5172
South Asian (SAS)
AF:
0.516
AC:
2483
AN:
4810
European-Finnish (FIN)
AF:
0.484
AC:
5103
AN:
10540
Middle Eastern (MID)
AF:
0.391
AC:
115
AN:
294
European-Non Finnish (NFE)
AF:
0.512
AC:
34809
AN:
67932
Other (OTH)
AF:
0.425
AC:
897
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1816
3631
5447
7262
9078
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
606
1212
1818
2424
3030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.472
Hom.:
62183
Bravo
AF:
0.410
Asia WGS
AF:
0.318
AC:
1103
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 11, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Phe2430Phe in exon 45 of DNAH11: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 49.2% (4012/8162) of European American chromosomes from a broad population by the NHLBI Exome Seq uencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs12536928).

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Primary ciliary dyskinesia Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Primary ciliary dyskinesia 7 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.32
CADD
Benign
6.6
DANN
Benign
0.76
PhyloP100
2.2
Mutation Taster
=89/11
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12536928; hg19: chr7-21765452; COSMIC: COSV60966351; API